Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease
Journal Title: International Neuroscience Conference (NEURO-2023) - Year 2023, Vol 4, Issue 1
Abstract
Alzheimer’s disease (AD) is the most common neurodegenerative disorder among the elderly. In the light of increasing AD prevalence and lack of effective treatment, new strategies to prevent or reverse this condition are needed. Levetiracetam (LEV) is a newer antiepileptic drug that is commonly used to treat the certain types of seizures. Researches indicated that LEV has several other pharmacological activities, including improvement of cognitive function. In this study, the recovery effects of chronic (28 days) administration of LEV (50, 100 and 150 mg/kg, ip) on cognitive deficits caused by the intracerebroventricular (icv) injection of streptozotocin (STZ), as a model for sporadic AD, were evaluated in rats. We also considered the protective effects of LEV against hippocampal cell loss, oxidative damage, acetylcholinesterase (AChE) activity, neuroinflammation, and tauopathy caused by STZ. LEV (100 and 150 mg/kg) significantly attenuated the STZ-induced learning and memory impairments in the passive avoidance and Morris water maze (MWM) tasks. In addition, LEV suppressed STZ-induced hippocampal neuronal loss, while restored alterations in the redox status (lipid peroxides and glutathione), AChE activity, proinflammatory cytokines (IL-1β, IL-6, TNF-α) and hyperphosphorylation of tau linked to STZ administration. In conclusion, our study demonstrated that LEV alleviated hippocampal cell death and memory deficits in STZ-AD rats, through mitigating of oxidative damage, the increased expressions of proinflammatory cytokines and tau hyperphosphorylation.
Authors and Affiliations
Hamid R. Sadeghnia*, Mohaddeseh Sadat Alavi, Sahar Fanoudi, Mahmoud Hosseini
Keywords
Related Articles
- EP ID EP747387
- DOI -
- Views 2
- Downloads 0
The effects of Minocycline on the neurological and inflammatory factors expression after severe traumatic brain injury in male rats: A molecular and histological study
Introduction: Traumatic brain injury (TBI) is a very complex disorder that includes different degrees of brain contusion, diffuse axonal damage, haemorrhage, and hypoxia. Minocycline is an antibiotic that acts through an...
Linagliptin inhibits the growth of human glioblastoma cells
Glioblastoma is among the most aggressive brain tumors. The prominent features of this tumor include aberrant cell proliferation, a high probability of recurrence, immunosuppression, severe angiogenesis, and infiltrative...
Association between systemic immune-inflammation index and disability among Polish ischemic stroke patients receiving intravenous thrombolysis: a single-center, prospective cohort study
The inflammatory response plays a central role in the pathophysiology of ischemic stroke. One of the newest laboratory markers with potential for predicting the outcomes of ischemic stroke patients is the systemic immune...
MRI-based quantification of grey matter reduction in brain areas along neural pathways in schizophrenia
Schizophrenia is a critical disorder with a difficult diagnosis and no promising treatment. Therefore, it is important to address the neurological variation and the brain abnormalities linked to schizophrenia. In this pa...
Comparative assessment of microvascular decompression and gamma knife radiosurgery for trigeminal neuralgia: efficacy in pain alleviation and complication profiles
Introduction: Trigeminal neuralgia (TN) represents an infrequent yet highly distressing condition characterized by unilateral, electric shock-like facial pain triggered even by the gentlest stimuli. In the therapeutic la...